Taking the pulse of clinical trials
Thursday, March 17, at 1:00 p.m. ET / 10:00 a.m. PT
Keeping track of clinical trials is a Herculean task, as millions of changes occur each year. STAT Trials Pulse is a new clinical intelligence platform that can help, allowing users to seamlessly keep tabs on the trials they care about, and find actionable insights that can drive a company’s strategic and financial direction.
Join experts at STAT for a discussion about how to use this new tool, developed in conjunction with Applied XL, to make sense of clinical trials data.
Speakers:
- Frank S. David, M.D., Ph.D., managing director, Pharmagellan
- Francesco Marconi, co-founder and CEO, Applied XL
- Matthew Herper, senior writer, medicine; editorial director of events, STAT
